Related Experiment Video
Updated: Jun 12, 2026
10:54
Optimization of Radiochemical Reactions using Droplet Arrays
Published on: February 12, 2021
Compounding pharmacy: old methods finding a new niche.
Charlotte Matheny1, Caren McHenry Martin
1Pharmerica, Greensboro, North Carolina, USA.
Summary
Pharmaceutical compounding, customizing medications for patients, has a long history. Pharmacists must understand current regulations for compounded medications, especially for elderly and long-term care patients.
Area of Science:
- Pharmacy
- Pharmacology
- Drug Compounding
Background:
- Pharmaceutical compounding involves pharmacists creating personalized medications.
- This practice has historical significance with fluctuating popularity.
- Customized medications are crucial for specific patient populations, including the elderly and long-term care residents.
Observation:
- The need for compounded medications varies over time.
- Elderly individuals and long-term care patients often require tailored pharmaceutical preparations.
- Pharmacists play a vital role in the compounding process.
Findings:
- The scope and regulations surrounding pharmaceutical compounding are subject to change.
- Awareness of current practices and legal frameworks is essential for pharmacists.
- Historical trends indicate a cyclical nature to the demand for compounded drugs.
Implications:
- Pharmacists must stay informed about evolving compounding regulations.
- Ensuring patient access to necessary customized medications is a key responsibility.
- Understanding the historical context of compounding aids in appreciating its current role.
Related Concept Videos
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:02Prescription, Nonprescription and Orphan Drugs
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
01:26Pharmaceutical Equivalents
As defined by regulatory standards, pharmaceutical equivalents require generic drug products to have identical dosage forms and chemically identical active pharmaceutical ingredients (APIs). They must adhere to compendial or applicable standards for potency, content uniformity, disintegration times, and dissolution rates. In the case of modified-release dosage forms, variations in drug content are permissible as long as the delivered amount remains consistent with the innovator drug product.
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...